loading
前日終値:
$21.02
開ける:
$20.5
24時間の取引高:
109.53K
Relative Volume:
0.08
時価総額:
$1.98B
収益:
$23.38M
当期純損益:
$-155.22M
株価収益率:
-9.5525
EPS:
-2.19
ネットキャッシュフロー:
$-134.36M
1週間 パフォーマンス:
-3.95%
1か月 パフォーマンス:
+5.18%
6か月 パフォーマンス:
-18.60%
1年 パフォーマンス:
-41.76%
1日の値動き範囲:
Value
$20.50
$20.99
1週間の範囲:
Value
$20.50
$22.86
52週間の値動き範囲:
Value
$13.45
$44.42

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Name
名前
Ideaya Biosciences Inc
Name
セクター
Healthcare (1174)
Name
電話
650-443-6209
Name
住所
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
職員
131
Name
Twitter
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
IDYA's Discussions on Twitter

IDYA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IDYA
Ideaya Biosciences Inc
20.91 1.98B 23.38M -155.22M -134.36M -2.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.67 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
536.33 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.87 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.86 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.08 28.51B 3.81B -644.79M -669.77M -6.24

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-18 開始されました Stephens Overweight
2024-11-05 ダウングレード Leerink Partners Outperform → Market Perform
2024-10-24 開始されました UBS Buy
2024-10-15 開始されました Cantor Fitzgerald Overweight
2024-07-08 開始されました Mizuho Outperform
2024-03-08 開始されました BTIG Research Buy
2023-08-08 開始されました SVB Securities Outperform
2023-05-24 開始されました Goldman Buy
2023-04-24 アップグレード Stifel Hold → Buy
2023-03-23 開始されました Berenberg Buy
2023-02-28 開始されました RBC Capital Mkts Outperform
2022-12-28 開始されました CapitalOne Overweight
2022-10-27 開始されました Citigroup Buy
2022-08-15 ダウングレード Stifel Buy → Hold
2022-07-18 再開されました Oppenheimer Outperform
2022-03-10 アップグレード Stifel Hold → Buy
2021-09-23 開始されました Stifel Hold
2021-06-04 再開されました Robert W. Baird Outperform
2021-03-11 開始されました Guggenheim Buy
2020-10-07 開始されました Wedbush Outperform
2020-09-01 開始されました Northland Capital Outperform
2020-07-13 アップグレード JP Morgan Neutral → Overweight
2020-06-17 繰り返されました H.C. Wainwright Buy
2020-04-06 開始されました H.C. Wainwright Buy
2020-03-13 開始されました ROTH Capital Buy
2019-10-17 開始されました Oppenheimer Outperform
2019-09-10 開始されました Robert W. Baird Outperform
2019-06-17 開始されました Citigroup Buy
2019-06-17 開始されました JP Morgan Neutral
2019-06-17 開始されました Jefferies Buy
すべてを表示

Ideaya Biosciences Inc (IDYA) 最新ニュース

pulisher
Jun 17, 2025

Rhumbline Advisers Increases Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Holdings Lifted by GAMMA Investing LLC - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Handelsbanken Fonder AB Raises Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on IDYA FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Transcript : IDEAYA Biosciences, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 10 - MarketScreener

Jun 09, 2025
pulisher
Jun 08, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 08, 2025
pulisher
Jun 02, 2025

IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events - Longview News-Journal

Jun 02, 2025
pulisher
Jun 02, 2025

IDEAYA Biosciences CEO Set for Major Healthcare Conference Double-Header: Jefferies and Goldman Sachs - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Eastern Progress

May 31, 2025
pulisher
May 30, 2025

Ideaya Biosciences announces inducement grants under Nasdaq listing rule - TipRanks

May 30, 2025
pulisher
May 30, 2025

IDEAYA Biosciences (IDYA) Grants Stock Options to New Employees | IDYA Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by Nuveen Asset Management LLC - Defense World

May 30, 2025
pulisher
May 25, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Price Target Raised to $66.00 - Defense World

May 25, 2025
pulisher
May 25, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives $54.27 Consensus PT from Brokerages - Defense World

May 25, 2025
pulisher
May 23, 2025

(IDYA) Proactive Strategies - news.stocktradersdaily.com

May 23, 2025
pulisher
May 22, 2025

JP Morgan Raises Price Target for IDEAYA Biosciences (IDYA) | ID - GuruFocus

May 22, 2025
pulisher
May 22, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Acquired by Ameriprise Financial Inc. - Defense World

May 22, 2025
pulisher
May 21, 2025

BNP Paribas Financial Markets Buys 10,543 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 21, 2025
pulisher
May 20, 2025

Jane Street Group LLC Reduces Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 20, 2025
pulisher
May 20, 2025

Bank of America Corp DE Acquires 41,390 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 20, 2025
pulisher
May 15, 2025

January 2026 Options Now Available For IDEAYA Biosciences - Nasdaq

May 15, 2025
pulisher
May 14, 2025

Ideaya Biosciences: Value Beyond Darovasertib With ADC Program IDE849 (NASDAQ:IDYA) - Seeking Alpha

May 14, 2025
pulisher
May 12, 2025

(IDYA) Investment Analysis - news.stocktradersdaily.com

May 12, 2025
pulisher
May 12, 2025

FY2025 EPS Estimates for IDYA Cut by Cantor Fitzgerald - Defense World

May 12, 2025
pulisher
May 12, 2025

Stifel Financial Corp Sells 3,834 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 12, 2025
pulisher
May 11, 2025

Dimensional Fund Advisors LP Has $8.91 Million Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

May 11, 2025
pulisher
May 10, 2025

16,769 Shares in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Acquired by Raymond James Financial Inc. - Defense World

May 10, 2025
pulisher
May 10, 2025

Brokers Issue Forecasts for IDYA Q2 Earnings - Defense World

May 10, 2025
pulisher
May 10, 2025

Leerink Partnrs Has Bullish Estimate for IDYA Q2 Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

IDEAYA Biosciences Receives Fast Track Designation for IDE161 in a Second Indication for the Treatment of Pretreated, Advanced or Metastatic HR+, Her2-, BRCA1/2 mutant Breast Cancer - Barchart.com

May 09, 2025
pulisher
May 07, 2025

Ideaya Biosciences (IDYA) Faces Market Reaction Following FDA Le - GuruFocus

May 07, 2025
pulisher
May 07, 2025

IDEAYA Biosciences Reports Q1 2025 Financial Results - TipRanks

May 07, 2025
pulisher
May 07, 2025

IDEAYA Biosciences (NASDAQ:IDYA) Shares Down 10.2% After Earnings Miss - Defense World

May 07, 2025
pulisher
May 06, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Bought by Mariner LLC - Defense World

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update - The Malaysian Reserve

May 06, 2025
pulisher
May 06, 2025

IDEAYA Gets FDA Clearance to Initiate Clinical Trial of Antibody Drug Conjugate Program in Solid Tumors - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Posts Q1 Net Loss; Cash Runway Extended Through 2029 - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

IDEAYA gets approval to begin trial for its antibody drug conjugate in solid tumors - Seeking Alpha

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Ideaya Biosciences (IDYA) Achieves Major Milestones in Oncology Programs | IDYA Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Ideaya Biosciences (IDYA) Advances with FDA Approval for IDE849 Trial | IDYA Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Announces US FDA IND-Clearance For IDE849, A Potential First-In-Class DLL3 TOP1 ADC, For A Phase 1 Study In Solid Tumors - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

FDA clears IDEAYA’s Phase 1 trial for new cancer drug By Investing.com - Investing.com South Africa

May 06, 2025
pulisher
May 06, 2025

FDA clears IDEAYA’s Phase 1 trial for new cancer drug - Investing.com

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

IDEAYA Biosciences Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors – Company Announcement - Financial Times

May 06, 2025
pulisher
May 05, 2025

IDEAYA Receives Fast Track Designation for Potential First-in-Class PARG Inhibitor, IDE161, for Treatment of Pretreated, Platinum-Resistant Advanced or Metastatic Ovarian Cancer Patients having tumors with BRCA1/2 Mutations - Barchart.com

May 05, 2025
pulisher
May 05, 2025

IDEAYA Biosciences Announces Phase 2 Expansion of Darovasertib and Crizotinib Combination in GNAQ/11 Metastatic Cutaneous Melanoma - Barchart.com

May 05, 2025
pulisher
May 05, 2025

Why IDEAYA Biosciences, Inc. (IDYA) is Among the Best Small Cap Stocks to Buy with the Biggest Upside Potential - Insider Monkey

May 05, 2025
pulisher
May 04, 2025

IDEAYA Biosciences (IDYA) to Release Quarterly Earnings on Tuesday - Defense World

May 04, 2025

Ideaya Biosciences Inc (IDYA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.69
price up icon 0.12%
$36.18
price up icon 0.58%
$21.00
price down icon 1.89%
$98.59
price down icon 1.88%
$107.07
price up icon 0.55%
biotechnology ONC
$242.16
price up icon 0.11%
大文字化:     |  ボリューム (24 時間):